- Home
- LYRA vs FEBO Comparison
LYRA vs FEBO Comparison
Compare LYRA & FEBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYRA
- FEBO
- Stock Information
- Founded
- LYRA 2005
- FEBO 1993
- Country
- LYRA United States
- FEBO Hong Kong
- Employees
- LYRA N/A
- FEBO N/A
- Industry
- LYRA Medical/Dental Instruments
- FEBO
- Sector
- LYRA Health Care
- FEBO
- Exchange
- LYRA Nasdaq
- FEBO Nasdaq
- Market Cap
- LYRA 15.0M
- FEBO 12.6M
- IPO Year
- LYRA 2020
- FEBO 2023
- Fundamental
- Price
- LYRA $7.95
- FEBO $1.06
- Analyst Decision
- LYRA Buy
- FEBO
- Analyst Count
- LYRA 2
- FEBO 0
- Target Price
- LYRA $16.00
- FEBO N/A
- AVG Volume (30 Days)
- LYRA 91.5K
- FEBO 22.0K
- Earning Date
- LYRA 08-13-2025
- FEBO 08-05-2025
- Dividend Yield
- LYRA N/A
- FEBO N/A
- EPS Growth
- LYRA N/A
- FEBO N/A
- EPS
- LYRA N/A
- FEBO N/A
- Revenue
- LYRA $1,185,000.00
- FEBO $17,110,653.00
- Revenue This Year
- LYRA N/A
- FEBO N/A
- Revenue Next Year
- LYRA $139.18
- FEBO N/A
- P/E Ratio
- LYRA N/A
- FEBO N/A
- Revenue Growth
- LYRA N/A
- FEBO 11.58
- 52 Week Low
- LYRA $3.81
- FEBO $0.82
- 52 Week High
- LYRA $37.50
- FEBO $15.48
- Technical
- Relative Strength Index (RSI)
- LYRA 41.08
- FEBO 49.81
- Support Level
- LYRA $7.77
- FEBO $1.05
- Resistance Level
- LYRA $8.67
- FEBO $1.07
- Average True Range (ATR)
- LYRA 0.45
- FEBO 0.06
- MACD
- LYRA -0.03
- FEBO 0.02
- Stochastic Oscillator
- LYRA 11.32
- FEBO 79.80
About LYRA Lyra Therapeutics Inc.
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.
About FEBO Fenbo Holdings Limited
Fenbo Holdings Ltd is a company engaged in producing premium personal care electric appliances, principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.